LPCAT2 and malignant colon neoplasm: To explore the dynamic changes in LPCAT2 expression during colon cancer progression, we established colitis-associated colon cancer (CAC) mouse model by challenging C57BL/6 mice with intraperitoneal injection of AOM and water-fed DSS (Fig. 1I).